Sunmax Biotechnology Co., Ltd. (4728)
TWSE
396.00
+1.50 (+0.38%)
Closed
Oct 8, 2026
Day's Range
396.00408.00
52 wk Range
350.00416.00
Financial Statements - 4728 - Sunmax Biotechnology Co., Ltd.
Revenue
2.02B▲ 113.5%
Net Income
725.74M▲ 6.8%Net Margin 35.8%
EBITDA
1.12B▲ 29.4%
Free Cash Flow
757.58M▲ 110.0%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 2.02B | 949.17M | 1.68B | 1.40B | 1.03B | 855.85M |
| Cost of Goods | 437.53M | 214.02M | 284.09M | 207.27M | 141.21M | 154.64M |
| Gross Profit | 1.58B | 735.15M | 1.40B | 1.19B | 894.44M | 701.20M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 998.30M | 539.51M | 894.79M | 767.60M | 367.61M | 329.93M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 1.01B | 838.69M | 909.39M | 777.17M | 357.48M | 337.75M |
| Income Tax | 288.82M | 159.28M | 283.68M | 243.34M | 111.84M | 99.68M |
| Net Income | 725.74M | 679.40M | 625.70M | 533.83M | 245.64M | 238.07M |
| EPS Basic | 13.33 | 12.47 | 11.49 | 9.8 | 4.51 | 4.37 |
| EPS Diluted | 13.31 | 12.46 | 11.47 | 9.79 | 4.51 | 4.37 |
| Basic Shares Outstanding | 54.46M | 54.46M | 54.46M | 54.46M | 54.46M | 54.46M |
| Diluted Shares Outstanding | 54.46M | 54.46M | 54.46M | 54.46M | 54.46M | 54.46M |
| Ebit | 1.01B | 840.14M | 912.33M | 778.52M | 360.29M | 340.67M |
| Ebitda | 1.12B | 866.95M | 985.29M | 835.82M | 418.39M | 380.24M |
| Net Income Continuous Operations | 1.01B | 838.69M | 909.39M | 777.17M | 357.48M | 337.75M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
